A new medication for treatment of dry mouth in Sjögren's syndrome.

I. al-Hashimi, S. E. Taylor

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Traditionally, treatment of dry mouth in SS is focused on palliative measures (using salivary substitutes). However, due to the dynamic nature of the oral cavity, the salivary substitute is removed from the mouth during swallowing. Therefore, the duration of effect of salivary substitutes is short. Another drawback is that salivary substitutes do not provide the protective roles of saliva. Effective treatment of dry mouth requires increasing salivary output. Gustatory stimulation of the salivary glands with sugar free gum and sugar free candies may be effective in inducing salivary output, however, they impose significant inconvenience on the patient which can compromise compliance. Pharmacological stimulants provide an alternative effective measure and improve compliance. Both Salagen and Evoxac are FDA approved salivary stimulants. They are effective, and safe given awareness of their indications, contraindications, potential adverse effects, and patient's tolerance.

Original languageEnglish (US)
Pages (from-to)262-266
Number of pages5
JournalTexas dental journal
Volume118
Issue number3
StatePublished - Jan 1 2001

Fingerprint

Mouth
Compliance
Candy
Pilocarpine
Gingiva
Therapeutics
Deglutition
Salivary Glands
Saliva
Pharmacology

Cite this

A new medication for treatment of dry mouth in Sjögren's syndrome. / al-Hashimi, I.; Taylor, S. E.

In: Texas dental journal, Vol. 118, No. 3, 01.01.2001, p. 262-266.

Research output: Contribution to journalArticle

@article{9f25d066fcd7461eac11a48269b2aec4,
title = "A new medication for treatment of dry mouth in Sj{\"o}gren's syndrome.",
abstract = "Traditionally, treatment of dry mouth in SS is focused on palliative measures (using salivary substitutes). However, due to the dynamic nature of the oral cavity, the salivary substitute is removed from the mouth during swallowing. Therefore, the duration of effect of salivary substitutes is short. Another drawback is that salivary substitutes do not provide the protective roles of saliva. Effective treatment of dry mouth requires increasing salivary output. Gustatory stimulation of the salivary glands with sugar free gum and sugar free candies may be effective in inducing salivary output, however, they impose significant inconvenience on the patient which can compromise compliance. Pharmacological stimulants provide an alternative effective measure and improve compliance. Both Salagen and Evoxac are FDA approved salivary stimulants. They are effective, and safe given awareness of their indications, contraindications, potential adverse effects, and patient's tolerance.",
author = "I. al-Hashimi and Taylor, {S. E.}",
year = "2001",
month = "1",
day = "1",
language = "English (US)",
volume = "118",
pages = "262--266",
journal = "Texas dental journal",
issn = "0040-4284",
publisher = "Texas Dental Association",
number = "3",

}

TY - JOUR

T1 - A new medication for treatment of dry mouth in Sjögren's syndrome.

AU - al-Hashimi, I.

AU - Taylor, S. E.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Traditionally, treatment of dry mouth in SS is focused on palliative measures (using salivary substitutes). However, due to the dynamic nature of the oral cavity, the salivary substitute is removed from the mouth during swallowing. Therefore, the duration of effect of salivary substitutes is short. Another drawback is that salivary substitutes do not provide the protective roles of saliva. Effective treatment of dry mouth requires increasing salivary output. Gustatory stimulation of the salivary glands with sugar free gum and sugar free candies may be effective in inducing salivary output, however, they impose significant inconvenience on the patient which can compromise compliance. Pharmacological stimulants provide an alternative effective measure and improve compliance. Both Salagen and Evoxac are FDA approved salivary stimulants. They are effective, and safe given awareness of their indications, contraindications, potential adverse effects, and patient's tolerance.

AB - Traditionally, treatment of dry mouth in SS is focused on palliative measures (using salivary substitutes). However, due to the dynamic nature of the oral cavity, the salivary substitute is removed from the mouth during swallowing. Therefore, the duration of effect of salivary substitutes is short. Another drawback is that salivary substitutes do not provide the protective roles of saliva. Effective treatment of dry mouth requires increasing salivary output. Gustatory stimulation of the salivary glands with sugar free gum and sugar free candies may be effective in inducing salivary output, however, they impose significant inconvenience on the patient which can compromise compliance. Pharmacological stimulants provide an alternative effective measure and improve compliance. Both Salagen and Evoxac are FDA approved salivary stimulants. They are effective, and safe given awareness of their indications, contraindications, potential adverse effects, and patient's tolerance.

UR - http://www.scopus.com/inward/record.url?scp=0035316428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035316428&partnerID=8YFLogxK

M3 - Article

C2 - 2001140001

AN - SCOPUS:0035316428

VL - 118

SP - 262

EP - 266

JO - Texas dental journal

JF - Texas dental journal

SN - 0040-4284

IS - 3

ER -